1. Home
  2. CYPH vs INLF Comparison

CYPH vs INLF Comparison

Compare CYPH & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$0.76

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

INLF

INLIF LIMITED

HOLD

Current Price

$0.19

Market Cap

59.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
INLF
Founded
2011
2016
Country
United States
China
Employees
6
156
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
59.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CYPH
INLF
Price
$0.76
$0.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.8M
2.5M
Earning Date
05-13-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$0.24
52 Week High
$3.70
$5.20

Technical Indicators

Market Signals
Indicator
CYPH
INLF
Relative Strength Index (RSI) 43.75 21.01
Support Level $0.54 N/A
Resistance Level $0.79 $0.77
Average True Range (ATR) 0.11 0.76
MACD -0.02 -0.41
Stochastic Oscillator 31.82 0.13

Price Performance

Historical Comparison
CYPH
INLF

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

Share on Social Networks: